Niagen Bioscience, Inc. SEC filings NAGE

Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Niagen Bioscience, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
10-Q Quarterly report May 18, 2020 Mar 31, 2020
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
10-Q Quarterly report Aug 10, 2017 Jul 1, 2017
10-Q Quarterly report May 11, 2017 Apr 1, 2017
10-Q Quarterly report Nov 10, 2016 Oct 1, 2016
10-Q/A Amended quarterly report Aug 26, 2016 Apr 2, 2016
10-Q Quarterly report Aug 11, 2016 Jul 2, 2016
10-Q Quarterly report May 12, 2016 Apr 2, 2016
10-Q Quarterly report Nov 12, 2015 Oct 3, 2015
10-Q Quarterly report Aug 13, 2015 Jul 4, 2015
10-Q Quarterly report May 14, 2015 Apr 4, 2015
10-Q Quarterly report Nov 6, 2014 Sep 27, 2014
10-Q Quarterly report Aug 12, 2014 Jun 28, 2014
10-Q Quarterly report May 8, 2014 Mar 29, 2014
10-Q/A Amended quarterly report Dec 5, 2013 Jun 29, 2013
10-Q/A Amended quarterly report Dec 5, 2013 Mar 30, 2013
10-Q Quarterly report Nov 21, 2013 Sep 28, 2013
10-Q Quarterly report Aug 13, 2013 Jun 29, 2013
10-Q Quarterly report May 10, 2013 Mar 30, 2013
10-Q Quarterly report Nov 8, 2012 Sep 29, 2012
10-Q/A Amended quarterly report Aug 10, 2012 Jun 30, 2012
10-Q Quarterly report Aug 9, 2012 Jun 30, 2012
10-Q Quarterly report May 10, 2012 Mar 31, 2012
10-Q Quarterly report Nov 10, 2011 Sep 30, 2011
10-Q/A Amended quarterly report Oct 12, 2011 Jul 2, 2011
10-Q Quarterly report Aug 11, 2011 Jul 2, 2011
10-Q Quarterly report May 12, 2011 Apr 2, 2011
10-Q Quarterly report Nov 16, 2010 Oct 2, 2010
10-Q Quarterly report Aug 17, 2010 Jul 3, 2010
10-Q Quarterly report May 18, 2010 Apr 3, 2010
10-Q Quarterly report Nov 17, 2009 Oct 3, 2009
10-Q Quarterly report Aug 18, 2009 Jul 4, 2009
10-Q Quarterly report May 15, 2009 Apr 4, 2009
10-Q Quarterly report Nov 12, 2008 Sep 27, 2008
10-Q Quarterly report Aug 12, 2008 Jun 28, 2008

Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
NAGE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Los Angeles, CA
SEC filer status
Large accelerated filer
SEC CIK
1386570
Former names
ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.